MARKET

STAA

STAA

Staar Surg
NASDAQ
19.42
-0.11
-0.56%
After Hours: 19.38 -0.04 -0.21% 16:20 05/09 EDT
OPEN
19.72
PREV CLOSE
19.53
HIGH
19.98
LOW
19.33
VOLUME
970.77K
TURNOVER
--
52 WEEK HIGH
49.86
52 WEEK LOW
13.50
MARKET CAP
961.80M
P/E (TTM)
-13.4432
1D
5D
1M
3M
1Y
5Y
1D
STAAR Surgical’s Earnings Call: Growth Amid Challenges
TipRanks · 3d ago
Staar Surgical Price Target Raised to $20.00/Share From $17.00 by Canaccord Genuity
Dow Jones · 3d ago
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Dow Jones · 3d ago
Canaccord Genuity Maintains Hold on Staar Surgical, Raises Price Target to $20
Benzinga · 3d ago
Staar Surgical: Hold Rating Amid Strong Q1 Performance and Strategic Adjustments
TipRanks · 3d ago
Staar Surgical: Hold Rating Amidst Uncertainties and Strategic Adjustments
TipRanks · 3d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Merus (MRUS), Staar Surgical (STAA) and Inogen (INGN)
TipRanks · 3d ago
Staar Surgical price target raised to $20 from $17 at Canaccord
TipRanks · 3d ago
More
About STAA
More
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
Recently
Symbol
Price
%Change

Webull offers STAAR Surgical Co stock information, including NASDAQ: STAA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STAA stock methods without spending real money on the virtual paper trading platform.